Idexx Laboratories | IDXX - Selling And Administration Expenses

Stock Price
565.93
Daily Change
5.00 0.89%
Monthly
-1.70%
Yearly
29.37%
Q2 Forecast
553.82

Idexx Laboratories reported $275.68M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Accuray USD 127.32M 500.16M Sep/2025
Align Technology USD 441.68M 23.88M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Fujifilm JPY 215.83B 2.93B Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
Masimo USD 128M 11.6M Dec/2025
Neogen USD 98.5M 9M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Zoetis USD 619M 40M Dec/2025